News und Analysen
Simulations Plus Reports First Quarter Fiscal 2022 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first
Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its Lixoft division, a leading
NanoString to Webcast Presentation from the 40th Annual JP Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a
Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call
Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the first quarter of fiscal year 2022, the period ended November 30, 2021, after the close of the
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has extended its
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope
Simulations Plus, Inc. (Nasdaq: SLP) is celebrating 25 years in business and continuing the commitment to improve public health through innovative solutions with a $25,000 donation to the
Owens & Minor to Present at Bank of America Leveraged Finance Conference
Owens & Minor, Inc. (NYSE-OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, today announced that Andy
DGAP-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
DGAP-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014 in Verbindung mit Art. 2 Abs. 2 und Abs. 3 der Delegierten Verordnung (EU) 2016/1052
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Net sales and earnings decline in 2022
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Umsatz und Ergebnisrückgang in 2022
Sichere dir das Top-Angebot: Olympus M.Zuiko DIGITAL ED 12-45mm F4.0 PRO – Perfektion trifft Ersparnis!
Sichere Dir Jetzt das Vielseitige Olympus OM SYSTEM M.Zuiko 14‑150mm F4‑5.6 II Objektiv zum Bestpreis!
Schnapp dir den ultimativen Allrounder: Olympus M.Zuiko Digital ED 12-200mm F3.5-6.3 jetzt 16% günstiger
Sichern Sie sich den Gaming-Thron: BigBuy Home Silla Gaming Genesis Nitro 650 zum unschlagbaren Preis!
DGAP-Adhoc: Geratherm Medical AG: Barkapitalerhöhung aus genehmigtem Kapital / Downlisting geplant
DGAP-Adhoc: Geratherm Medical AG: - Capital Increase against cash contributions from authorized capital / - Downlisting envisaged
DGAP-News: MicroVision to Participate in Virtual Fireside Chat Webcast and One-On-One Investor Meetings on April 13, 2022
DGAP-News: Eckert & Ziegler: Radboud University Medical Center in den Niederlanden behandelt ersten Patienten mit PENTIXAFOR
DGAP-News: Eckert & Ziegler: Radboud University Medical Center Netherlands to Image First Patient with PENTIXAFOR
DGAP-Adhoc: Geratherm Medical AG: Geratherm Medical AG announces preliminary figures for financial year 2021
DGAP-Adhoc: Geratherm Medical AG: Geratherm Medical AG gibt vorläufige Zahlen für das Geschäftsjahr 2021 bekannt
DGAP-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2022 with Deviation in Earnings and Confirms Annual Forecast for 2022
DGAP-Adhoc: Eckert & Ziegler veröffentlicht vorläufige Zahlen zu Q1/2022 mit Abweichung beim Ergebnis und bestätigt Jahresprognose 2022.
DGAP-News: MicroVision Inc.: MicroVision Appoints Jeffrey Herbst to Board of Directors